English Other languages Società

Early outpatient treatment of COVID-19 – IppocrateOrg

5 Aprile 2022 by

… The pandemic … was declared in march 2020

… pathophysiology soon provided a strong rationale for the early use of anti-inflammatory, antiplatelet and anticoagulant drugs

… the evidence was only slowly and partially incorporated into institutional guidelines

… a sample of COVID-19 patients taken care of in Italy by physicians volunteering within the IppocrateOrg Association, one of the main international assistance networks

… between 1st november 2020 and 31st march 2021

… in COVID-19 stage 0 (15,6%), 1 (50,0%), 2a (28,8%), 2b (5,6%)

… overweight (26%) or obese (11,5%)

… chronic comorbidities (34,9%), mainly cardiovascular (23%) and metabolic (13,3%)

… Hospitalization occurred in 5,8% of total cases, mainly in patients taken care of when in stage 2b

… 390 patients (99,6%) recovered, one patient (0,2%) was lost at follow up, and one patient (0,2%) died after hospitalization

… COVID-19 lethality in our cohort was 0,2%, while the overall COVID-19 lethality in Italy in the same period was between 3% and 3,8%

 

Share: